Marker Therapeutics Inc (MRKR)

[rfj1862]

TPIV 200 with ovarian cancer is set to report phase 2 results Q4 of 2019. I believe they had to wait for 55 events first. The longer it takes to get to the events the better the data remember that. That's because events means progression/death. If they hit the 55 events fast, that means patients are dying faster on treatment

It's 55 events, which can occur in either arm, so the amount of time it takes for events to occur has absolutely no correlation with differences between the arms.